Article
Advances in gene therapy for cystic fibrosis lung disease.
Human molecular genetics - 1 Oct 2019
Yan Ziying, McCray Paul B, Engelhardt John F
Abstract excerpt
Cystic fibrosis (CF) is a multiorgan recessive genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Gene therapy efforts have focused on treating the lung, since it manifests the most significant life-threatening disease. Over two decades have past since the first CF lung gene therapy trials and significant advances in the therapeutic implementation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
